Clinical Trial Update: Melphalan Chemoreduction for Ocular Melanoma [Phase 1, Phase 2]

View source ↗

Summary

Ongoing Phase 1/Phase 2 clinical trial evaluating melphalan chemoreduction for uveal melanoma, currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uveal Melanoma

Drugs mentioned

• Melphalan (Melphalan)

Snippet

Sponsor: Hospital das Clínicas de Ribeirão Preto | Conditions: Uveal Melanoma | Phase 1, Phase 2 | Status: ENROLLING_BY_INVITATION